Medical testing services for detection, diagnostic or treatment purposes marketed and sold to healthcare providers and insurers, namely, third-party testing of patient urine, blood and/or oral fluids; medical services, namely, medication monitoring and drug detection services to evaluate patient treatment plans and improve clinical outcomes and patient safety; drug use testing services, namely, testing patient urine, blood and/or oral fluid for medication or drug abuse and/or compliance with patient prescriptions; medical pharmacogenetic testing service for detection, diagnostic or treatment purposes that predict a patient's genetic predisposition to metabolizing medications; medical services, namely, providing medication therapy management based on predictive modeling of patient population data